Atai Life Sciences N.V. (FRA:9VC)
Germany · Delayed Price · Currency is EUR 4.951
-0.049 (-0.98%)
At close: Oct 23, 2025
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of €1.02 billion as of October 23, 2025. Its market cap has increased by 498.51% in one year.
Market Cap
1.02B
Enterprise Value
952.42M
Revenue
1.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.95
Market Cap Chart
Since June 18, 2021, Atai Life Sciences's market cap has decreased from 2.50B to 1.02B, a decrease of -59.06%. That is a compound annual growth rate of -18.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 1.04B | 382.95% |
| Dec 31, 2024 | 215.57M | 1.79% |
| Dec 29, 2023 | 211.77M | -48.71% |
| Dec 30, 2022 | 412.86M | -61.61% |
| Dec 31, 2021 | 1.08B | -57.03% |
| Jun 18, 2021 | 2.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 275.84B |
| Siemens Aktiengesellschaft | 187.55B |
| Deutsche Telekom AG | 143.21B |
| Allianz SE | 133.19B |
| Siemens Energy AG | 81.62B |
| Rheinmetall AG | 81.03B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.41B |
| Deutsche Bank Aktiengesellschaft | 54.96B |